Peak Bio, Inc. Other Income and Expense
Peak Bio, Inc. reported Other Income and Expense of $3.21 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2024-11-12
- Peak Bio, Inc. nonoperating income (expense) for the quarter ending 2024-09-30 was $3.21M, a 31.32% increase year-over-year.
- Peak Bio, Inc. nonoperating income (expense) for the quarter ending 2024-06-30 was -$687.24K.
- Peak Bio, Inc. nonoperating income (expense) for the quarter ending 2024-03-31 was -$229.87K, a 150.94% decline year-over-year.
- Peak Bio, Inc. nonoperating income (expense) for the quarter ending 2023-12-31 was $620.90K.
- Peak Bio, Inc. nonoperating income (expense) for fiscal 2023 was $239.67K.
- Peak Bio, Inc. nonoperating income (expense) for fiscal 2022 was -$1.31M, a 253.78% decline from fiscal 2021.
- Peak Bio, Inc. nonoperating income (expense) for fiscal 2021 was $855.02K.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2024-09-30 | $3.21M 10-Q · filed 2024-11-12 | $2.52M derived: sum of 2 quarters · filed 2024-11-12 | $2.29M 10-Q · filed 2024-11-12 | $2.91M derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | -$687.24K 10-Q · filed 2024-08-23 | -$917.11K 10-Q · filed 2024-08-23 | -$296.21K derived: sum of 3 quarters · filed 2024-08-23 | $2.15M derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-03-31 | -$229.87K 10-Q · filed 2024-08-23 | $391.02K derived: sum of 2 quarters · filed 2024-08-23 | $2.83M derived: sum of 3 quarters · filed 2024-11-12 | -$441.45K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-12-31 | $620.90K derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-06 | $3.06M derived: sum of 2 quarters · filed 2024-11-12 | -$211.57K derived: sum of 3 quarters · filed 2024-11-12 | $239.67K 10-K · filed 2024-08-06 |
| 2023-09-30 | $2.44M 10-Q · filed 2024-11-12 | -$832.47K derived: sum of 2 quarters · filed 2024-11-12 | -$381.23K 10-Q · filed 2024-11-12 | -$1.95M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$3.27M 10-Q · filed 2024-08-23 | -$2.82M 10-Q · filed 2024-08-23 | -$4.39M derived: sum of 3 quarters · filed 2024-08-23 | -$4.46M derived: sum of 4 quarters · filed 2024-08-23 |
| 2023-03-31 | $451.24K 10-Q · filed 2024-08-23 | -$1.12M derived: sum of 2 quarters · filed 2024-08-23 | -$1.18M derived: sum of 3 quarters · filed 2024-08-23 | -$1.09M derived: sum of 4 quarters · filed 2024-08-23 |
| 2022-12-31 | -$1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-06 | -$1.64M derived: sum of 2 quarters · filed 2024-08-06 | -$1.54M derived: sum of 3 quarters · filed 2024-08-06 | -$1.31M 10-K · filed 2024-08-06 |
| 2022-09-30 | -$68.74K 10-Q · filed 2024-06-25 | $30.43K derived: sum of 2 quarters · filed 2024-06-25 | $252.55K 10-Q · filed 2024-06-25 | |
| 2022-06-30 | $99.17K 10-Q · filed 2023-08-18 | $321.29K 10-Q · filed 2023-08-18 | ||
| 2022-03-31 | $222.11K 10-Q · filed 2023-07-12 | |||
| 2021-12-31 | $855.02K 10-K · filed 2023-06-29 |